Abstract
The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile, cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into sub microscopic nuclei occurs from these super saturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.
Keywords: bile salts, cholesterol, crystals, gallstone, phospholipids, ursodeoxycholate
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Title: Modulation of Cholesterol Crystallization in Bile. Implications for Non- Surgical Treatment of Cholesterol Gallstone Disease
Volume: 5 Issue: 2
Author(s): Piero Portincasa, Antonio Moschetta, Karel J. van Erpecum, Michele Vacca, Michele Petruzzelli, Giuseppe Calamita, Giuliano Meyer and Giuseppe Palasciano
Affiliation:
Keywords: bile salts, cholesterol, crystals, gallstone, phospholipids, ursodeoxycholate
Abstract: The first step in cholesterol gallstone disease is precipitation of cholesterol crystals in bile. In gallbladder bile, cholesterol is normally solubilized together with bile salts and phospholipids to form mixed micellar structures. When cholesterol in bile is in excess, vesicles (i.e. phospholipid-cholesterol globular structures: liquid crystals) form which become supersaturated in cholesterol. Early aggregation and precipitation of cholesterol molecules into sub microscopic nuclei occurs from these super saturated vesicles. This crucial step is followed by precipitation and agglomeration of cholesterol crystals which then become visible at light microscopy. Here we describe the mechanism of cholesterol crystallization and its modulation in vivo and in vitro. Recent advances on the role of ursodeoxycholate as an agent preventing the precipitation of cholesterol crystals in bile will be highligthed.
Export Options
About this article
Cite this article as:
Portincasa Piero, Moschetta Antonio, van Erpecum J. Karel, Vacca Michele, Petruzzelli Michele, Calamita Giuseppe, Meyer Giuliano and Palasciano Giuseppe, Modulation of Cholesterol Crystallization in Bile. Implications for Non- Surgical Treatment of Cholesterol Gallstone Disease, Current Drug Targets - Immune, Endocrine & Metabolic Disorders 2005; 5 (2) . https://dx.doi.org/10.2174/1568005310505020177
DOI https://dx.doi.org/10.2174/1568005310505020177 |
Print ISSN 1568-0088 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5917 |